Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30152% above fair value
$56.95+1.58 (+2.85%)
Close on Nov 18, 2026Market cap $3.40BP/E –Yield –
Axogen operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Axogen's operating cash flow for the twelve months ending Sep 30, 2026 was $28.36M, up 335.7% year over year. For fiscal 2025 it was $812.00K, down 82.1% from the year before. The highest annual figure on record is $4.54M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $812.00K | -82.1% |
| FY2024 | Dec 31, 2024 | $4.54M | – |
| FY2023 | Dec 31, 2023 | -$5.72M | – |
| FY2022 | Dec 31, 2022 | -$16.07M | – |
| FY2021 | Dec 31, 2021 | -$13.41M | – |
| FY2020 | Dec 31, 2020 | -$9.63M | – |
| FY2019 | Dec 31, 2019 | -$19.87M | – |
| FY2018 | Dec 31, 2018 | -$17.86M | – |
| FY2017 | Dec 31, 2017 | -$9.24M | – |
| FY2016 | Dec 31, 2016 | -$11.24M | – |
| FY2015 | Dec 31, 2015 | -$13.05M | – |
| FY2014 | Dec 31, 2014 | -$10.45M | – |
| FY2013 | Dec 31, 2013 | -$10.44M | – |
| FY2012 | Dec 31, 2012 | -$8.66M | – |
| FY2011 | Dec 31, 2011 | -$7.08M | – |
| FY2010 | Dec 31, 2010 | -$3.94M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $16.54M | +413.1% |
| Q2 FY2026 | Jun 30, 2026 | $7.22M | -6.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.57M | – |
| Q4 FY2025 | Dec 31, 2025 | $3.04M | -65.2% |
| Q3 FY2025 | Sep 30, 2025 | $3.22M | -17.4% |
| Q2 FY2025 | Jun 30, 2025 | $7.73M | +85.6% |
| Q1 FY2025 | Mar 31, 2025 | -$13.18M | – |
| Q4 FY2024 | Dec 31, 2024 | $8.74M | – |
| Q3 FY2024 | Sep 30, 2024 | $3.90M | +139.9% |
| Q2 FY2024 | Jun 30, 2024 | $4.17M | +1326.4% |
| Q1 FY2024 | Mar 31, 2024 | -$12.27M | – |
| Q4 FY2023 | Dec 31, 2023 | -$211.00K | -115.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.63M | – |
| Q2 FY2023 | Jun 30, 2023 | $292.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.42M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.36M | – |
| Q3 FY2022 | Sep 30, 2022 | -$689.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.69M | – |
| Q1 FY2022 | Mar 31, 2022 | -$11.05M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.51M | -153.4% |
| Q3 FY2021 | Sep 30, 2021 | -$376.00K | -114.4% |
| Q2 FY2021 | Jun 30, 2021 | -$695.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.82M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.84M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.62M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.05M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.33M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.86M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.81M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.87M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.98M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.97M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.08M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.84M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.05M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.16M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.07M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.95M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.46M | – |
See a number that looks wrong?